A detailed history of Orin Green Financial, LLC transactions in Bio Line Rx Ltd. stock. As of the latest transaction made, Orin Green Financial, LLC holds 51,000 shares of BLRX stock, worth $196,860. This represents 0.0% of its overall portfolio holdings.

Number of Shares
51,000
Previous 43,000 18.6%
Holding current value
$196,860
Previous $23,000 52.17%
% of portfolio
0.0%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 19, 2025

BUY
$0.2 - $0.6 $1,600 - $4,800
8,000 Added 18.6%
51,000 $11,000
Q2 2024

Jul 30, 2024

BUY
$0.56 - $0.86 $24,080 - $36,980
43,000 New
43,000 $24,000

Others Institutions Holding BLRX

About BioLineRx Ltd.


  • Ticker BLRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,524,500
  • Market Cap $237M
  • Description
  • BioLineRx Ltd., a clinical-stage biopharmaceutical development company, focuses on oncology. The company develops Motixafortide, a peptide, which has completed Phase 3 clinical trials for the treatment of autologous stem cell mobilization and Phase 2a clinical trials for the treatment of pancreatic cancer; and that is in Phase 2 clinical trials ...
More about BLRX
Track This Portfolio

Track Orin Green Financial, LLC Portfolio

Follow Orin Green Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orin Green Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orin Green Financial, LLC with notifications on news.